This research aims to provide consensus guidance on using dexamethasone as an antiemetic for pediatric patients undergoing chemotherapy.
Delphi panel consensus statements.
Focus on chemotherapy-naïve pediatric patients.
Consideration of moderate and highly emetogenic chemotherapy (MEC and HEC).
Dexamethasone is recommended for nausea and vomiting prevention.
Consensus highlights its effective role as an antiemetic in pediatric chemotherapy.
Abstract
The consensus statements of the Delphi panel provide guidance on dexamethasone use as an antiemetic in chemotherapy-naïve pediatric patients receiving MEC or HEC.